Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

May 30, 2015 8:36 AM ET


Company Overview of OncoMed Pharmaceuticals, Inc.

Key Executives for OncoMed Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Paul J. Hastings 239 RelationshipsChairman, Chief Executive Officer and President54
Sunil Patel 14 RelationshipsChief Financial Officer and Senior Vice President of Corporate Development & Finance42
Jakob Dupont M.D.No RelationshipsChief Medical Officer and Senior Vice President49
Austin Gurney Ph.D.No RelationshipsSenior Vice President of Molecular and Cellular Biology50
Alicia J. Hager J.D., Ph.D.No RelationshipsVice President and General Counsel44
View More Key Executives

OncoMed Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Paul J. Hastings 239 RelationshipsOncoMed Pharmaceuticals, Inc.54
Jonathan D. Root M.D. 87 RelationshipsU.S. Venture Partners54
Jack W. Lasersohn J.D. 29 RelationshipsThe Vertical Group61
Michael S. Wyzga 58 RelationshipsRadius Health, Inc.59
Laurence A. Lasky Ph.D. 65 RelationshipsOncoMed Pharmaceuticals, Inc.63
View All Board Members

OncoMed Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Michael S. Wyzga58 Relationships2 Executives
Compensation Committee M.D.Jonathan D. Root87 Relationships1 Executives
Nominating Committee J.D.Jack W. Lasersohn29 Relationships3 Executives
Corporate Governance Committee J.D.Jack W. Lasersohn29 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation$9.3M
Not meaningful
Total Value of Options$469.5K
Compensation as of Fiscal Year 2014
OncoMed Pharmaceuticals, Inc. CEO Compensation
Industry Average


GP Batteries International Limited Announces Executive Appointments
May 28, 2015 9:15 AM ET
HRG Group, Inc. Announces Resignation of Michael Sena as Senior Vice President and Chief Accounting Officer
May 27, 2015 8:41 PM ET
Timo Hiekkaranta to Leave Suominen Corporation
May 27, 2015 6:00 AM ET
The Clorox Company Announces Board Changes
May 15, 2015 12:46 PM ET
Ryan Announces Executive Changes
May 13, 2015 4:55 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OncoMed Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at